Join our upcoming webinar to learn about the MSDA Test in a clinical setting on Dec. 13, 12:00 PM EST Register Today
September 18 – September 20, 2024
Copenhagen, Denmark
We are excited to engage with leading experts in MS at the 2024 ECTRIMS Meeting, where we’ll have the opportunity to present our innovative approach to revolutionizing care in MS.
Join us at the ECTRIMS 2024 Product Theatre to hear our collaborators discuss the science behind our precision care platform.
Session Description
The promise of precision medicine, transitioning from science to practice. This session focuses on the clinical applicability and impact of a multi-protein biomarker approach using the Octave Multiple Sclerosis Disease Activity (MSDA) Blood Test. The session will present validated and practical applications of The MSDA Test in clinical settings, supported by key research and publications. Learn how this multi-protein biomarker approach contributes to establishing a baseline and improving longitudinal clinical management in MS care.
Session Details
Moderator
Panelist
Panelist
Panelist
Panelist
Visit us during the ECTRIMS 2024 Poster Presentations, where both our Medical Team and collaborators will be presenting the following:
Poster Session 1 – Wednesday, September 18, 2024, 4:15 – 6:15 pm (16:15 – 18:15) CEST
Poster Session 2 – Thursday, September 19, 2024, 4:45 – 6:45 pm (16:45 – 18:45) CEST
We are looking forward to meeting you in Copenhagen. Please stop by our booth to say hello, and schedule time with the Octave team.
Booth Details